Synthesis of lipid A and its analogues for investigation of the structural basis for their bioactivity

Abstract

As a step to elucidate the structural requirements for the endotoxic and antagonistic activity of lipid A derivatives, we have focused, in the present study, on the effects of the acyl moieties and acidic groups at the 1- and 4′- positions. We synthesized a new analogue corresponding to Rubrivivax gelatinosus lipid A, which has a characteristic symmetrical distribution of acyl groups on the two glucosamine residues with shorter acyl groups (decanoyl groups [C₁₀] and lauryl groups [C₁₂]) than Escherichia coli lipid A. Carboxymethyl analogues in which one of the phosphates was replaced with a carboxymethyl group were also synthesized with different distribution of acyl groups. Biological tests revealed that the distribution of acyl groups strongly affected the bioactivity. The synthetic Ru. gelatinosus type lipid A showed potent antagonistic activity against LPS, whereas its 1-O-carboxymethyl analogue showed weak endotoxic activity. These results demonstrated that when the lipid A has shorter (C₁₀, C₁₂) hexa-acyl groups, the bioactivity of lipid A is easily affected with small structural difference, such as the difference of acidic group or the distribution of acyl groups, and the bioactivity changes from endotoxic to agonistic or vice versa at this structural boundary for the bioactivity. We also designed, based on molecular mechanics calculations, and synthesized lipid A analogues possessing acidic amino acid residues in place of the non-reducing end phosphorylated glucosamine. Definite switching of the endotoxic or antagonistic activity was also observed depending on the difference of the acidic groups (phosphoric acid or carboxylic acid) in the lipid A analogues.

Keywords

Lipid A Rubrivivax gelatinosus conformation IL-6 induction

References

Liu WC , Oikawa M. , Fukase K. , Suda Y. , Kusumoto S. A divergent synthesis of lipid A and its chemically stable unnatural analogues . Bull Chem Soc Jpn 1999; 72: 1377—1385.

Oikawa M. , Shintaku T. , Fukuda N. et al. NMR conformational analysis of biosynthetic precursor-type lipid A: monomolecular state and supramolecular assembly. Org Biomol Chem 2004; 2: 3557—3565.

Fukase K. , Fukase Y. , Oikawa M. , Liu WC , Suda Y. , Kusumoto S. Divergent synthesis and biological activities of lipid A analogues of shorter acyl chains. Tetrahedron Lett 1998; 54: 4033—4050.

Hofmann E. , Ferguson A. , Diederichs K. , Welte W. Siderophoremediated iron transport: crystal structure of FhuA with bound lipopolysaccharide . Science 1998; 282: 2215—2220.

Schromm AB , Brandenburg K. , Loppnow H. et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 2000; 267: 2008—2013.

Masoud H. , Lindner B. , Weckesser J. , Mayer H.

The structure of the lipid A component of Rhodocyclus gelatinosus Dr2 lipopolysaccharide. System

Appl Microbiol 1990; 13: 227—233.

Kusumoto S. , Fukase K. , Fukase Y. et al. Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs. J Endotoxin Res 2003; 9: 361—366.

Tamai R. , Asai Y. , Hashimoto M. et al. Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4. Immunology 2003; 110: 66—72.

Johnson DA , Keegan DS , Sowell CG et al. 3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities. J Med Chem 1999 ; 42: 4640—4649.

10.

Matsuura M. , Kojima Y. , Homma JY et al. Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A. FEBS Lett 1984; 167: 226—230.

11.

Seydel U. , Oikawa M. , Fukase K. , Kusumoto S. , Brandenburg K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem 2000; 267: 3032—3039.

12.

Mueller M. , Lindner B. , Kusumoto S. , Fukase K. , Schromm AB , Seydel U. Aggregates are the biologically active units of endotoxin. J Biol Chem 2004; 279: 26307—26313.

13.

Saitoh S. , Akashi S. , Yamada T. et al. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization . Int Immunol 2004; 16: 961—969.

14.

Christ WJ , Asano O. , Robidoux AL et al. E5531, a pure endotoxin antagonist of high potency. Science 1995; 268: 80—83.

15.

Rossignol D. , Hawkins L. , Christ W. et al. In: Brade H , Opal SM , Vogel SN , Morrison DC. (eds) Synthetic Endotoxin Antagonists . New York: Marcel Dekker, 1999; 699—717, and the references cited therein.

16.

Triantafilou M. , Brandenburg K. , Kusumoto S. et al. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem J 2004; 381: 527—536.

17.

Gustmann T. , Schromm AB , Koch Mhj et al. Lipopolysaccharide-binding protein-mediated interaction of lipid A from different origin with phospholipid membranes. Phys Chem Chem Phys 2000; 2: 4521—4528.